HDAC9 and acute lymphoblastic leukemia: To validate and broaden these findings, we initially investigated the effects of HDACi on Notch3 in T-ALL cells treated in vitro with the pan-HDAC inhibitor Trichostatin A (TSA) at 0.5 μM, a concentration selected on the basis of published data [16, 17].